Less radiation after lumpectomy for women with early breast cancer is feasible.
It would seem so in women with early breast cancer, according to the results of two large trials, but United States and European researchers are still skeptical about the long-term adverse effects.
Findings from the first trial, the Standardization of Breast Radiotherapy Trial, which followed 2,000 lumpectomy patients for 5 years, suggest that the total amount of radiation can be safely reduced by about 10 Gy (from the usual 50 Gy) and delivered in fewer sessions
(13 instead of 25) over a 5-week period, an approach known as hypofractionation, with no greater rates of local recurrence or adverse effects.
The second trial performed in Canada, which followed 1,000 women for 10 years and which compared a 3-week schedule of 42.5 Gy in 16 fractions against standard treatment, also found no statistically significant difference between the groups in terms of local recurrence or adverse effects.
McNeil C. Less radiation after lumpectomy in breast cancer: new results stir debate. J Natl Cancer Inst. 2008;100:910-911.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More